ASCO Genitourinary Cancers Symposium


 

ASCO GU 2022: Phase II/III Clinical Results of IL-15RαFc Superagonist N-803 With BCG in BCG-Unresponsive NMIBC

27 views
March 8, 2022
Comments 0
Login to view comments. Click here to Login